Osteolytic metastases in cancer of the prostate
Cayla, J.; Rondier, J.; Jabre, E.; de Saint-Maur, P.; Couturaud, M.
Annales de Medecine Interne 123(4): 307-322
1972
ISSN/ISBN: 0003-410X PMID: 5077034 Document Number: 51932
Document emailed within 1 workday
Related Documents
Elomaa, I.; Blomqvist, C.; Porkka, L.; Holmström, T.; Taube, T.; Lamberg-Allardt, C.; Borgström, G.H. 1988: Clodronate for osteolytic metastases due to breast cancer Biomedicine and PharmacoTherapy 42(2): 111-116Theriault, R. 1996: Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients British Journal of Clinical Practice. Suppl 87: 8
Mbalaviele, G.; Dunstan, C.R.; Sasaki, A.; Williams, P.J.; Mundy, G.R.; Yoneda, T. 1996: E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model Cancer Research 56(17): 4063-4070
Rosen, L.S.; Gordon, D.; Kaminski, M.; Howell, A.; Belch, A.; Mackey, J.; Apffelstaedt, J.; Hussein, M.; Coleman, R.E.; Reitsma, D.J.; Seaman, J.J.; Chen, B.L.; Ambros, Y. 2001: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial Cancer Journal 7(5): 377-387
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Paterson, A.H. 1987: Bone metastases in breast cancer, prostate cancer and myeloma Bone 8(Suppl 1): S17-S22
Weber, W.; Rösler, H.P.; Doll, G.; Dostert, M.; Kutzner, J.; Schild, H. 1992: The percutaneous irradiation of osteolytic bone metastases--a course assessment Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 168(5): 275-280
Watanabe, A.; Taniguchi, M. 2005: A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 65-67
Saad, F.; Chi, K.; Fleshner, N. 2004: The role of bisphosphonates in the management of bone metastases in prostate cancer Canadian Journal of Urology 11(5): 2376-2382
Keller, E.T. 2002: The role of osteoclastic activity in prostate cancer skeletal metastases Drugs of Today 38(2): 91-102
Bourlon, M.T.; Glodé, L.M.; Crawford, E.D. 2014: Base of the skull metastases in metastatic castration-resistant prostate cancer Oncology 28(12): 1115-1116; 1124
Zhao, W.; Deng, H.; Jie, P.; Qing, C.; Zhang, X. 2010: Preliminary application of strontium-89 for the treatment of bone metastases from prostate cancer Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(6): 1251-1254
Maruo, H.; Usui, Y. 2016: A Case of Synchronous Vp3 Hepatocellular Carcinoma and Prostate Cancer Accompanied by Bone Metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 1797-1799
Soffen, E.M.; Greenberg, A.; Baumann, J.; Corn, B.W. 1997: The role of strontium-89 systemic radiotherapy in the management of osseous metastases from prostate cancer Techniques in Urology 3(2): 76-80
Colović, V.; Basić, D.T.; Oprić, D.; Djokić, J.Hadzi. 2009: Multiple cutaneous metastases of advanced prostate cancer: case report and a review of the literature Acta Chirurgica Iugoslavica 56(1): 105-107
Ismail, A.H.; Altaweel, W.; Chevalier, S.; Kassouf, W.; Aprikian, A.G. 2004: Expression of vascular endothelial growth factor-A in human lymph node metastases of prostate cancer Canadian Journal of Urology 11(1): 2146-2150
Minami, H.; Kanagawa, K.; Watanabe, Y.; Sakakura, T.; Ito, T.; Kawamura, M.; Nakatani, T.; Kishimoto, T. 2001: Complete remission of brain metastases from prostate cancer by gamma knife radiosurgery: a case report Hinyokika Kiyo. Acta Urologica Japonica 47(5): 333-336
Behrakis, P.; Koutsilieris, M. 1997: Pulmonary metastases in metastatic prostate cancer: host tissue-tumor cell interactions and response to hormone therapy Anticancer Research 17(3a): 1517-1518
Chang, P.L.; Wang, T.M.; Huang, S.T.; Hsieh, M.L.; Tsui, K.H.; Lai, R.H. 1999: Use of a medical decision support system to improve the preoperative diagnosis of prostate cancer with pelvic lymph node metastases Changgeng Yi Xue Za Zhi 22(4): 556-564
2016: Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC) Clinical Advances in Hematology and Oncology: H&o 14(4 Suppl. 5): 10-11